Penserra Capital Management’s Vicarious Surgical RBOT Stock Holding History

Penserra Capital Management’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-129	Closed	-$11K	–	1170
2022 Q2	$11K	Buy	129 +17	+15%	+$2.08K	﹤0.01%	1230
2022 Q1	$16K	Sell	112 -8	-7%	-$1.49K	﹤0.01%	1313
2021 Q4	$38K	Sell	120 -198	-62%	-$69.8K	﹤0.01%	1091
2021 Q3	$142K	Sell	318 -68	-18%	-$21.5K	﹤0.01%	686
2021 Q2	$115K	Sell	386 -228	-37%	-$67.9K	﹤0.01%	759
2021 Q1	$183K	Buy	+614	New	+$188K	﹤0.01%	594

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

HVCM

Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penserra Capital Management's RBOT Position: Q3 2022 in Review

Penserra Capital Management sold out of Vicarious Surgical (RBOT) in Q3 2022, closing a stake of 129 shares — an estimated $11K sold.

Penserra Capital Management first reported a position in RBOT in Q1 2021 and held it in 6 quarters. The position peaked at $183K in Q1 2021. 76 funds tracked by Wall St. Rank hold RBOT as of Q3 2022.

Penserra Capital Management reported no remaining Vicarious Surgical position as of Q3 2022 after selling out during the quarter.
Penserra Capital Management sold 129 Vicarious Surgical shares in Q3 2022, an estimated $11K.
Penserra Capital Management first reported a position in Vicarious Surgical in Q1 2021 and held it in 6 quarters.
Penserra Capital Management's Vicarious Surgical position peaked at $183K in Q1 2021.
76 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.